HomeZTS • NYSE
add
Zoetis Inc
Previous close
$127.69
Day range
$127.75 - $129.31
Year range
$115.25 - $181.85
Market cap
56.49B USD
Avg Volume
4.52M
P/E ratio
29.75
Dividend yield
1.56%
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 2.40B | 0.50% |
Operating expense | 774.00M | 0.91% |
Net income | 721.00M | 5.72% |
Net profit margin | 30.04 | 5.18% |
Earnings per share | 1.70 | 7.59% |
EBITDA | 1.07B | 2.59% |
Effective tax rate | 18.71% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.08B | 21.59% |
Total assets | 15.16B | 5.59% |
Total liabilities | 9.76B | 6.99% |
Total equity | 5.40B | — |
Shares outstanding | 440.69M | — |
Price to book | 10.44 | — |
Return on assets | 15.93% | — |
Return on capital | 19.28% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 721.00M | 5.72% |
Cash from operations | 938.00M | -1.37% |
Cash from investing | -160.00M | 10.11% |
Cash from financing | -134.00M | 78.66% |
Net change in cash | 649.00M | 363.57% |
Free cash flow | 337.75M | -29.10% |
About
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index. Wikipedia
Founded
1952
Headquarters
Website
Employees
13,800
